Past year: ▼ 10%(12.90 – 18.68 AUD)
Each one in plain English, with the numbers worked through for a shareholder.
12 Dec 2023capital raising announcement● NeutralMajor
NexGen renewed its at-the-market share program, now up to C$500M (up from C$250M), with Virtu, running to 8 January 2026. The January 2023 agreement was terminated. Shares sell at market price, so more dilution is possible; proceeds fund development, exploration and general purposes.
12 Dec 2023other● Neutral
Blake, Cassels & Graydon LLP consent to the reference to its legal opinion in the 11 December 2023 prospectus supplement. Routine consent; no new information.
12 Dec 2023capital raising announcement● Neutral
ASX cleansing prospectus lodged 12 December 2023, offering one CDI at A$10.50 (raising A$10.50). It is a technical device so shares issued, such as under the ATM, can be freely resold on ASX; not a real fundraising.
12 Dec 2023other● Neutral
Farris LLP consent to the reference to its name and opinion in the 11 December 2023 prospectus supplement. Routine consent; no new information.
11 Dec 2023other● Neutral
Kevin Small's consent, as a qualified person and Senior VP Operations and Engineering, to use of his reviewed technical information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Director Trevor Thiele's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
SLR International's consent, signed by Mark Mathisen, to use of Arrow feasibility study information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023capital raising announcement● Neutral
Final C$500M short form base shelf prospectus dated 8 December 2023, allowing shares, warrants, units, subscription receipts and debt to be sold over 25 months. It replaces the preliminary version; no specific raising or price is set yet.
11 Dec 2023other● Neutral
KPMG consents to its 24 February 2023 audit report on the 2022 and 2021 financial statements being incorporated into the 8 December 2023 prospectus. Routine consent; no new financial information.
11 Dec 2023other● Neutral
Mark Hatton's consent, as a qualified person, to use of Arrow feasibility study information (February 2021, amended March 2021) in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Director Donald Roberts's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
Director Warren Gilman's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
British Columbia Securities Commission receipt, also covering Ontario, for the final base shelf prospectus dated 8 December 2023. Regulatory paperwork with no new facts.
11 Dec 2023other● Neutral
Chair Christopher McFadden's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
Paul O'Hara's consent, as a qualified person, to use of Arrow feasibility study information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Exploration Manager Jason Craven's consent, as a qualified person, to use of his reviewed technical information in the 8 December 2023 prospectus. Routine consent; no new data.
5 Dec 2023other● Neutral
November 2023 monthly securities statement: ASX CDIs rose about 5.6m to 34,650,252 through transfers. Common shares not in CDIs fell to 488,176,470 and options to 48,450,802. Debenture securities unchanged at 16.27m. Administrative.
4 Dec 2023capital raising announcement● Neutral
Preliminary filing dated 1 December 2023 for a new C$500M base shelf prospectus (shares, warrants, units, debt and more) over 25 months. It is not yet final, and not offered in Australia. Presumably renews the existing shelf (inference); no raising yet.
4 Dec 2023other● Neutral
British Columbia Securities Commission receipt, also covering Ontario, for the preliminary base shelf prospectus dated 1 December 2023. Regulatory paperwork with no new facts.
4 Dec 2023other● Neutral
CFO Benjamin Salter's certificate that NexGen meets the criteria to file a short form base shelf prospectus, dated 1 December 2023. Compliance paperwork with no new information.
21 Nov 2023investor presentation● Neutral
NexGen announced a Q3 conference call on 22 November 2023 to update on the 100%-owned Rook I Project. Topics include the provincial environmental approval, federal permitting status, the confirmation program and recent financing. A notice of a call, with no new results.
10 Nov 2023regulatory community update▲ GoodMajor
NexGen received Saskatchewan ministerial environmental assessment approval to develop its 100%-owned Rook I project, stated to be the first such uranium approval in the province in over 20 years. This resolves the provincial review; federal responses are all submitted.
6 Nov 2023other● Neutral
October 2023 monthly securities statement: ASX CDIs rose about 2.6m to 29,070,082 through transfers. Common shares not in CDIs fell to 493,203,306. Debenture-related securities were unchanged at 16.27m. Administrative.
3 Nov 2023quarterly activities report● Neutral
Management commentary for the quarter and nine months to 30 September 2023. Text is truncated to the contents page and introduction, so no results or new facts can be drawn from it.
3 Nov 2023half year report● Neutral
Unaudited September 2023 nine-month statements: cash rose to C$370.4m from C$134.4m at December 2022, helped by the debenture financing and at-the-market sales. Convertible debentures were C$189.2m. Nine-month net loss was C$89.8m. Total equity C$664.7m.
3 Nov 2023other● Neutral
CEO Leigh Curyer's standard certification of the September 2023 interim filings. Compliance paperwork with no new information.
3 Nov 2023other● Neutral
CFO Ben Salter's standard certification of the September 2023 interim filings, now signed as Chief Financial Officer. Compliance paperwork with no new information.
4 Oct 2023other● Neutral
September 2023 monthly securities statement: ASX CDIs rose about 4.4m to 26,447,035 through transfers. Common shares not in CDIs rose to 495,826,353, and debenture-related securities rose to 16.27m. Administrative.
4 Oct 2023capital raising announcement● Neutral
Third refresh supplementary prospectus dated 4 October 2023 restarting the quotation timing for the ASX cleansing offer. Relates to the existing C$250M at-the-market program running to 29 January 2025. Procedural; no new raising.
25 Sept 2023debt financing▲ GoodMajor
The US$110M, 9.0% convertible debenture financing closed, maturing 22 September 2028, convertible at US$6.76. Cash reserves are about C$330M. QRC will convert its 2020 US$15M debentures into about 8.6M shares. Establishment fee was 634,615 shares.
